Results
1 -
10 of
71Kollektives Wissen zum Wohle der Patienten, Info Onkologie Resistance to crizotinib and therapeutic options, Guide to Targeted Therapies: Treatment Resistance in Lung Cancer ALK Mutant, Molecular Targeted Therapy of Lung Cancer Mechanism of Resistance to Targeted Molecular Therapy, Molecular Targeted Therapy of Lung Cancer Targeted Therapy und Precision Medicine, Der Internist Antitumor activity of alectinib, a selective ALK inhibitor, in an ALK-positive NSCLC cell line harboring G1269A mutation, Cancer Chemotherapy and Pharmacology Antitumor activity of the selective ALK inhibitor alectinib in models of intracranial metastases, Cancer Chemotherapy and Pharmacology Clinical challenges in targeting anaplastic lymphoma kinase in advanced non-small cell lung cancer, Cancer Chemotherapy and Pharmacology